Products
Online Inquiry
DB07268
Cat. No.:
0225LY-1069
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
DB07268 is a selective JNK1 inhibitor with high enzymatic affinity, making it a promising candidate for targeted therapies where JNK1 activity is a primary factor.
Synonym:
929007-72-7; 2-((2-((3-Hydroxyphenyl)amino)pyrimidin-4-yl)amino)benzamide; DB-07268; 4-(2-carbamoylanilino)-2-(3-hydroxyanilino)pyrimidine; 2-((2-(3-Hydroxyanilino)pyrimidin-4-yl)amino)benzamide; Benzamide, 2-((2-((3-hydroxyphenyl)amino)-4-pyrimidinyl)amino)-; 2-[[2-(3-hydroxyanilino)pyrimidin-4-yl]amino]benzamide
CAS No.:
929007-72-7
Compound CID:
16058637
Formula:
C17H15N5O2
Formula Weight:
321.33
Specification
Targets&IC50:
JNK1: 9 nM.
Relative Density:
1.427 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
DB07268 can be used in signaling research to explore the selective and potent inhibition of the c-Jun N-terminal kinase pathway.
Library Information
Target:
JNK
Receptor:
JNK1
Pathways:
MAPK signaling; Inflammation; Apoptosis
Plate Number:
AOCL-14
Plate Location:
g4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 155.6 mM
